Arteriovenous malformations epidemiology and demographics: Difference between revisions
No edit summary |
No edit summary |
||
Line 8: | Line 8: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Congenital disorders]] | |||
[[Category:Cardiology]] | |||
[[Category:Neurology]] | |||
[[Category:Disease]] | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} |
Revision as of 17:28, 30 January 2013
Arteriovenous malformations Microchapters |
Differentiating Arteriovenous malformations from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Arteriovenous malformations epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Arteriovenous malformations epidemiology and demographics |
FDA on Arteriovenous malformations epidemiology and demographics |
CDC on Arteriovenous malformations epidemiology and demographics |
Arteriovenous malformations epidemiology and demographics in the news |
Blogs on Arteriovenous malformations epidemiology and demographics |
Directions to Hospitals Treating Arteriovenous malformations |
Risk calculators and risk factors for Arteriovenous malformations epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kalsang Dolma, M.B.B.S.[2]
Overview
An estimated 300,000 people in the US have AVMs, of which 12% (approximately 36,000) will exhibit symptoms that differ greatly in severity.